Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN113666909B details a green synthesis route for Topiroxostat ensuring high purity and supply chain stability for global pharmaceutical manufacturers seeking reliable partners.
Patent CN108503573B details a high-purity Brivaracetam route eliminating chiral separation. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN103880859B details a robust route for Vitamin H intermediates. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity thieno-imidazole-diketone.
Novel synthesis method for fluorinated isoxazoles via electrophilic cyclization. Offers mild conditions and high yield for pharmaceutical intermediate manufacturing.
Patent CN111039893B reveals a metal-free NCS/TBHP oxidation route for benzothiazole derivatives, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Advanced synthesis of pazopanib hydrochloride intermediates via safe reductive amination. Cost-effective, scalable routes for API manufacturing supply chains.
Patent CN104109182B details a safer gemcitabine hydrochloride synthesis route ensuring high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN110194735B details a visible light catalytic method for chiral amines. Offers high ee values and metal-free conditions for efficient API intermediate manufacturing.
Patent CN112174893B details a novel palladium-catalyzed synthesis for 2,4,5-trimethyl-1H-imidazolecarboxylate, offering superior purity and catalytic efficiency for pharmaceutical manufacturing.
Novel Lewis acid-promoted [4+2] cyclization for 3,4-pyridinediimides. High atom economy, wide substrate scope, ideal for API and functional material manufacturing.
Patent CN113651663A reveals a green one-pot palladium-catalyzed method for ortho-deuteration, offering reliable supply chain solutions and cost reduction in pharmaceutical intermediates manufacturing.
Novel one-pot Ferrier rearrangement using FeCl3 catalyst. Reduces steps, enhances supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114249690A reveals a novel DBU-catalyzed route for Roxadustat. Achieve high purity and reduced manufacturing costs with our scalable pharmaceutical intermediate solutions.
Patent CN103772282B reveals a mild four-step synthesis for AMPA receptor intermediates. This route offers significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN115181103A details a scalable Baricitinib method reducing Impurity G. Ideal for reliable API intermediate suppliers seeking cost-effective manufacturing.
Novel patent CN104402726B offers efficient synthesis for complex annulene derivatives, ensuring high purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN114934287A details a metal-free electrochemical route for fluoroalkyl sulfonamides, offering greener API manufacturing and reduced heavy metal contamination risks.
Patent CN106831765A reveals Rhodium-catalyzed cyanation for high-purity imidazopyridine intermediates. Achieve cost reduction in pharmaceutical intermediate manufacturing with scalable methods.
Patent CN103554229B introduces a novel solid phase synthesis method for buserelin offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel synthesis route for methyl piperidinyl acetate intermediate offers high yield and cost efficiency for pharmaceutical manufacturing supply chains.